Skip to content
★ Sign in to follow
TF

Ted Fjällman

Index Pharmaceuticals Holding
Insider activity · 24 months3 buys0 salesCumulative net flow
Total declarations
9
Company
1
▲ Purchases (7 ops.)
€124k
▼ Sales (0 ops.)
—

Latest filing published 21 Oct 2026 for Index Pharmaceuticals Holding, €13k.

Filing timeline

BuySale
Ted Fjällman

Insider track record

Disclosed buys
7
Disclosed sells
0
Signal history

Closed purchases

Market purchases
7

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Ted Fjällman: trading record in brief

Ted Fjällman discloses dealings in Index Pharmaceuticals Holding to Finansinspektionen. Over a trading history stretching from 14 June 2024 to 21 October 2026, the count stands at 9 filings.

Purchases make up the whole of the open-market record (7 purchases, €124k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2026 alone, the filings show 3 purchases and no sales.

In size, the median ticket on the buying side is €20k. Of 4 purchases, 1 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The newest entry dates from 21 October 2026: an open-market purchase of €13k, in Index Pharmaceuticals Holding. The median gap between a trade and its publication by Finansinspektionen is 2 days. The legal deadline for notifying a trade is three business days (MAR article 19). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Companies and markets linked to Ted Fjällman

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations9 total
  • ▲
    Verkställande direktör (VD)ExecutivesIndex Pharmaceuticals Holding
    144,183 SEK0FI-SE
    9,213 shares@ SEK 15.65AktieISIN SE0022421467FI:csv-4e573c585fe6a49c1ef9
    Canonical exit: 14 Jan 2027 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesIndex Pharmaceuticals Holding
    146,736 SEK0FI-SE
    9,622 shares@ SEK 15.25AktieISIN SE0022421467FI:csv-59b50f9bdcaab7245e56
    Canonical exit: 17 Jan 2027 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesIndex Pharmaceuticals Holding
    140,321 SEK0FI-SE
    9,386 shares@ SEK 14.95AktieISIN SE0022421467FI:csv-92c9af90ed5d8a181a78
    Canonical exit: 19 Jan 2027 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesIndex Pharmaceuticals Holding
    243,577 SEK22FI-SE
    5,639 shares@ SEK 43.1950.5% of flowAktieISIN SE0022421467FI:csv-9ecd382e5bcc471f43ba
    Canonical exit: 15 Jan 2025 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesIndex Pharmaceuticals Holding
    269,739 SEK22FI-SE
    6,273 shares@ SEK 43.000.5% of flowAktieISIN SE0022421467FI:csv-9dd674a8fc86e8d6c819
    Canonical exit: 4 Nov 2024 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesIndex Pharmaceuticals Holding
    231,015 SEK22FI-SE
    4,744 shares@ SEK 48.69620.5% of flowAktieISIN SE0022421467FI:csv-2ca9db7a0501fc05ce23
    Canonical exit: 16 Oct 2024 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesIndex Pharmaceuticals Holding
    237,409 SEK40FI-SE
    454,807 shares@ SEK 0.5220.5% of flowAktieISIN SE0008966295FI:csv-c005697d5a49ee619665
    Canonical exit: 12 Sept 2024 (T+90)
  • ●
    Verkställande direktör (VD)ExecutivesIndex Pharmaceuticals Holding
    2M SEK22FI-SE
    3,372,052 shares@ SEK 0.5063.5% of flowAktieISIN SE0008966295FI:csv-556b0c8f405a06708c01
  • ●
    Verkställande direktör (VD)ExecutivesIndex Pharmaceuticals Holding
    46M SEK30FI-SE
    91,045,403 shares@ SEK 0.50694.5% of flowAktieISIN SE0008966295FI:csv-06e6c91c6edd238031d8

9 of 9 declarations